Prevalence and predictors of clinically significant statin–drug interactions among Yemeni patients taking statins for primary and secondary prevention of cardiovascular disease-Reference-Cited by-同舟云学术

Prevalence and predictors of clinically significant statin–drug interactions among Yemeni patients taking statins for primary and secondary prevention of cardiovascular disease

Published:2022-05-13 Issue:6 Volume:38 Page:889-899
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Al-Ashwal Fahmi Y.¹²^ORCID,Sulaiman Syed Azhar Syed¹^ORCID,Sheikh Ghadzi Siti Maisharah¹^ORCID,Kubas Mohammed Abdullah²^ORCID,Halboup Abdulsalam³^ORCID

Affiliation:

1. Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

2. Clinical Pharmacy Department, University of Science and Technology Hospital (USTH), Sana'a, Yemen

3. Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University of Science and Technology, Sana’a, Yemen

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2072088

Reference79 articles.

1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

2. Statins in the primary prevention of cardiovascular disease

3. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

4. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

5. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of an Educational Intervention on Enhancing Clinical Knowledge of Physicians and Pharmacists Regarding Statins and Monitoring Parameters: The Experience of a Tertiary Teaching Hospital;Advances in Medical Education and Practice;2024-04

2. Physicians and pharmacists’ clinical knowledge of statin therapy and monitoring parameters, and the barriers to guideline implementation in clinical practice;PLOS ONE;2023-01-20